Delivery Order SPE2DB20D3103-SPE2DB22FP1M8
- Not listed
- This federal contract award, SPE2DB22D3009|SPE2DB25FAH17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,083.96 firm fixed-price delivery order is for the supply of 4,566,196,865 units of the antibiotic medication Cefazolin 2 g/50 ml-dextrose. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award, valued at $1,162.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cefazolin 1 gm vials, a type of antibiotic medication. The contract has an ultimate completion date of December 18, 2023 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for pharmaceutical products and medical supplies to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceuticals and medical products to the federal government. The contract, valued up to $1,284.72, is for the delivery of the drug Cefazolin 1 g/50 ml-dextrose. This is a firm-fixed price delivery order contract with an ultimate completion date of April 22, 2024....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,083.96, is for the delivery of 4565910632 - Cefazolin 2 G/50 ML-Dextroses, a critical medical product. This is a Firm Fixed Price Delivery Order contract with a completion date of September 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,968,915 units of the pharmaceutical product Cefazolin 2 G/50 ML-Dextroses. The contract, valued at $3,478.11, has an ultimate completion date of March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) with DLA valued at up...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,228.56 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of Cefazolin 2 g/50 ml-dextrose, a generic antibiotic medication, to support military healthcare programs. The contract has a completion date of December 19, 2024 and is priced on a firm-fixed-price basis. Amerisourcebergen is a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,218.68 for the supply of 4,566,770,365 units of the drug Cefazolin 2 G/50 ML-Dextroses. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to support military healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of December 20, 2024. No set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cefazolin 2 g/50 mL-Dextroses medication. The contract, valued at $2,766.72, is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $2,303.16 Firm Fixed Price delivery order is for the supply of Cefazolin 2 G/50 ML-Dextrose, a critical antibiotic medication. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
- The federal contract award SPE2DX15D6028|SPE2DX25FWFTV was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,210.32 firm fixed-price delivery order is for the supply of 4,566,605,401 units of Cefazolin 1GM 24S, a critical antibiotic medication. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FP1M8Delivery Order
This federal contract award, valued at $1,337.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,557,742,874 units of Cefazolin 1 g/50 ml-dextrose, a critical antibiotic medication used in various medical treatments. The contract is a Firm Fixed Price Delivery Order with a completion date of July 11, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which specializes in pharmaceutical distribution to government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/8/22 |